SCHEMBL9974600

SCHEMBL9974600

CCOC(=O)c1cc2cc(Cl)ncc2n1CCCCF

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.43
CCR9 P51686 2/20 0.42
KDM4E B2RXH2 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
NOD2 Q9HC29 2/20 0.40
NOD1 Q9Y239 2/20 0.40
NPSR1 Q6W5P4 3/20 0.39
MAPT P10636 3/20 0.39
MAPK1 P28482 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
LMNA P02545 1/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
ALDH1A1 P00352 4/20 0.37
TSHR P16473 2/20 0.37
HTT P42858 2/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20951622 0.81 QRFPR (0.44) CNR2CCR9KDM4ESMN1; SMN2CRHBP
SCHEMBL30617317 0.81 QRFPR (0.44) CNR2CCR9KDM4ESMN1; SMN2CRHBP
SCHEMBL16235855 0.79 CCR9 (0.39) CCR9KDM4ESMN1; SMN2CRHBPCRHR2
SCHEMBL16254720 0.78 CCR9 (0.39) CCR9KDM4ESMN1; SMN2CRHBPCRHR2
SCHEMBL17556112 0.78 CCR9 (0.39) CCR9KDM4ESMN1; SMN2CRHBPCRHR2
SCHEMBL2815834 0.76 NOD2 (0.51) CCR9KDM4ESMN1; SMN2NOD2NOD1
Hydrochloric Acid SCHEMBL28848977 0.73 KDM4E (0.45) CNR2KDM4ESMN1; SMN2CRHBPCRHR2
Hydrochloric Acid SCHEMBL30104789 0.72 KDM4E (0.43) KDM4ESMN1; SMN2CRHBPCRHR2NOD2
SCHEMBL24187332 0.72 KDM4E (0.44) KDM4ESMN1; SMN2CRHBPCRHR2NOD2
SCHEMBL7911379 0.72 CCR9 (0.43) CCR9KDM4ESMN1; SMN2NOD2NOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160251377-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN SCIENCES IRELAND UC (IE) 2016-09-01 US claimed
US-9896459-B2 Azaindoles as respiratory syncytial virus antiviral agents JANSSEN SCIENCES IRELAND UC (IE) 2018-02-20 US disclosed
US-9896459-B2 Azaindoles as respiratory syncytial virus antiviral agents JANSSEN SCIENCES IRELAND UC (IE) 2018-02-20 US disclosed
EP-2651936-B1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN SCIENCES IRELAND UC (IE) 2017-02-22 EP disclosed
US-20160251377-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN SCIENCES IRELAND UC (IE) 2016-09-01 US disclosed
US-20160251377-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN SCIENCES IRELAND UC (IE) 2016-09-01 US disclosed
US-9339494-B2 Azaindoles as respiratory syncytial virus antiviral agents JANSSEN SCIENCES IRELAND UC (IR) 2016-05-17 US disclosed
US-9339494-B2 Azaindoles as respiratory syncytial virus antiviral agents JANSSEN SCIENCES IRELAND UC (IR) 2016-05-17 US disclosed
US-20150231119-A1 Azaindoles As Respiratory Syncytial Virus Antiviral Agents JANSSEN SCIENCES IRELAND UC (IE) 2015-08-20 US disclosed
US-20150231119-A1 Azaindoles As Respiratory Syncytial Virus Antiviral Agents JANSSEN SCIENCES IRELAND UC (IE) 2015-08-20 US disclosed
US-9051317-B2 Azaindoles as respiratory syncytial virus antiviral agents JANSSEN SCIENCES IRELAND UC (IE) 2015-06-09 US disclosed
US-9051317-B2 Azaindoles as respiratory syncytial virus antiviral agents JANSSEN SCIENCES IRELAND UC (IE) 2015-06-09 US disclosed
US-20130267556-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN R&D IRELAND (IE) 2013-10-10 US disclosed
US-20130267556-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN R&D IRELAND (IE) 2013-10-10 US disclosed
WO-2012080450-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN R&D IRELAND (IE) 2012-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150231119-A1 Azaindoles As Respiratory Syncytial Virus Antiviral Agents AZI2, CCNI, ZC3HAV1 CNR2 4714/4885CCR9 3295/4885KDM4E 1448/4885
US-20160251377-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS AZI2, CCNI, ZC3HAV1 CNR2 4714/4885CCR9 3295/4885KDM4E 1448/4885
US-20130267556-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS AZI2, CCNI, ZC3HAV1 CNR2 4714/4885CCR9 3295/4885KDM4E 1448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.